Brief: Aim Immunotech Provides Routine Update On Annual Filings
13/04/2026 23:01
April 13 (Reuters) - AIM ImmunoTech Inc AIM.A: AIM IMMUNOTECH PROVIDES ROUTINE UPDATE ON ANNUAL FILINGS AIM IMMUNOTECH INC - FY2025 AUDITED FINANCIALS INCLUDE GOING CONCERN EMPHASIS OF MATTER AIM IMMUNOTECH INC - EXPECTS NEXT DURIPANC STUDY UPDATE IN JUNE 2026 Source text: ID:nGNX6mxPvb Further company coverage: AIM.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential